Aberdeen, Highlands and Inverness Section: Oral cancer

What to expect

This interactive lecture will cover 21st century head and neck cancer early detection, diagnosis and management. James will discuss early lesions, diagnostic work up and surgical management. The event will also cover the role of immunotherapy in 2026 in the post Keynote 689 trial era.

Timings

18:00 Registration and light refreshments

18:30 Lecture - James A McCaul

20:00 End of lecture

Learning objectives

• Gain confidence in recognising oral lesions to refer to the maxillofacial team
• Understand the specific process of urgent suspicion of cancer (USOC) referral to ensure that the patient with the suspicious lesion gets to a USOC appointment with the maxillofacial cancer team efficiently
• Gain clear understanding of the impact oral cancer treatment on patients who will return to your care as cancer survivors.

Development outcomes

C

Meet the speaker

Jim qualified in medicine and dentistry, both with honours, and won ten undergraduate prizes and medals prior to completing higher training in the West of Scotland and his PhD in Cancer Science at the CRUK Scotland Institute. He was Consultant Surgeon in Yorkshire from 2006 and then in London at The Royal Marsden Hospital and Northwick Park Hospital before moving to Scotland in 2017. He is Professor Emeritus at the University of Bradford Institute for Cancer Therapeutics.

With 13 national and international awards, Jim was presented with the British Association of Oral and Maxillofacial Surgeons (BAOMS) President’s award for research optimising major surgery in 2012 and the BAOMS Surgery Prize 2014 in recognition of his international contribution. His team also won the BAOMS Norman Rowe Clinical Research Prize in 2014.

Jim is Chief Investigator of the CRUK Lugol's iodine in head and neck cancer surgery (LIHNCS) trial and the LISTER trial. His research is in minimising impact and optimising outcomes from head and neck cancer surgery and effectively treating after-effects, such as osteoradionecrosis. His work on the human microbiome (The VOLCANIC Trial) investigates dysbiosis in the microbiota in the gut, circulation and oral cavity. He is co-investigator in eight clinical trials in the UK and collaborates with internationally.

Jim is Assistant Editor of the International Journal of Surgery and IJS Case Reports, and was Associate Editor of British Journal of Oral and Maxillofacial Surgery until 2014. He reviews for 17 other international journals and is author of five book chapters, 113 peer reviewed research papers and more than 170 research abstracts. His first book for the open market, Face to Face was published in 2018 by Transworld (Penguin) and is an Amazon best seller.

In his private practice, Jim has a holistic approach to patients requiring all aspects of facial surgery including removal of facial lesions, skin cancer surgery, facial plastic surgery, salivary gland surgery and dentoalveolar surgery.